0 374

Cited 10 times in

Feasibility of single vocal cord irradiation as a treatment strategy for T1a glottic cancer

DC Field Value Language
dc.contributor.author이창걸-
dc.contributor.author정승연-
dc.date.accessioned2020-09-28T11:41:18Z-
dc.date.available2020-09-28T11:41:18Z-
dc.date.issued2020-05-
dc.identifier.issn1043-3074-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/179251-
dc.description.abstractBackground: Generally, radiotherapy for patients with early glottic cancer includes treatment of the whole larynx. This study was conducted to evaluate the treatment outcomes and toxicity in patients who received single vocal cord irradiation (SVCI) for T1a classification glottic cancer. Methods: A total of 34 patients diagnosed with clinical T1aN0M0 classification squamous cell carcinoma of the glottis who received radiotherapy to the single vocal cord were included for analysis. Results: Median follow-up period was 41.3 months (range, 6.4-124.5 months). The 3-year and 5-year local control (LC) rates were both 96.8%. Grade 3 radiation dermatitis was observed as severe acute toxicity in two (6%) patients. No patients experienced any severe late toxicity events during follow-up. Conclusions: SVCI showed good LC, low acute and late toxicities, and reasonable voice recovery. SVCI may be considered a feasible treatment strategy for patients with T1a glottic cancer.-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherJohn Wiley And Sons-
dc.relation.isPartOfHEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titleFeasibility of single vocal cord irradiation as a treatment strategy for T1a glottic cancer-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Radiation Oncology (방사선종양학교실)-
dc.contributor.googleauthorSeung Yeun Chung-
dc.contributor.googleauthorChang Geol Lee-
dc.identifier.doi10.1002/hed.26052-
dc.contributor.localIdA03240-
dc.contributor.localIdA05411-
dc.relation.journalcodeJ00963-
dc.identifier.eissn1097-0347-
dc.identifier.pmid31854475-
dc.identifier.urlhttps://onlinelibrary.wiley.com/doi/full/10.1002/hed.26052-
dc.subject.keywordhead and neck cancer-
dc.subject.keywordlaryngeal neoplasms-
dc.subject.keywordlocal neoplasm recurrence-
dc.subject.keywordradiotherapy-
dc.subject.keywordtoxicity-
dc.contributor.alternativeNameLee, Chang Geol-
dc.contributor.affiliatedAuthor이창걸-
dc.contributor.affiliatedAuthor정승연-
dc.citation.volume42-
dc.citation.number5-
dc.citation.startPage854-
dc.citation.endPage859-
dc.identifier.bibliographicCitationHEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, Vol.42(5) : 854-859, 2020-05-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Radiation Oncology (방사선종양학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.